[Federal Register Volume 88, Number 135 (Monday, July 17, 2023)]
[Notices]
[Pages 45428-45429]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-15061]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[Document Identifier: CMS-10174]


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

AGENCY: Centers for Medicare & Medicaid Services, Health and Human 
Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is 
announcing an opportunity for the public to comment on CMS' intention 
to collect information from the public. Under the Paperwork Reduction 
Act of 1995 (PRA), Federal agencies are required to publish notice in 
the Federal Register concerning each proposed collection of 
information, including each proposed extension or reinstatement of an 
existing collection of information, and to allow a second opportunity 
for public comment on the notice. Interested persons are invited to 
send comments regarding the burden estimate or any other aspect of this 
collection of information, including the necessity and utility of the 
proposed information collection for the proper performance of the 
agency's functions, the accuracy of the estimated burden, ways to 
enhance the quality, utility, and clarity of the information to be 
collected, and the use of automated collection techniques or other 
forms of information technology to minimize the information collection 
burden.

DATES: Comments on the collection(s) of information must be received by 
the OMB desk officer by August 16, 2023.

ADDRESSES: Written comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
    To obtain copies of a supporting statement and any related forms 
for the proposed collection(s) summarized in this notice, please access 
the CMS PRA website by copying and pasting the following web address 
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.

FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786-4669.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. The term ``collection of 
information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and 
includes agency requests or requirements that members of the public 
submit reports, keep records, or provide information to a third party. 
Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires 
Federal agencies to publish a 30-day notice in the Federal Register 
concerning each proposed collection of information, including each 
proposed extension or reinstatement of an existing collection of 
information, before submitting the collection to OMB for approval. To 
comply with this requirement, CMS is publishing this notice that 
summarizes the following proposed collection(s) of information for 
public comment:
    1. Type of Information Collection Request: Revision of the 
currently approved collection; Title of Information Collection: 
Collection of Prescription Drug Data from MA-PD, PDP and Fallout Plans/
Sponsors for Medicare Part D Payments; Use: The PDE data is used in the 
Payment Reconciliation System to perform the annual Part D payment 
reconciliation, any PDE data within the Coverage Gap Phase of the Part 
D benefit is used for invoicing in the CGDP, and the data are part of 
the report provided to the Secretary of the Treasury for Section 9008.
    The information users will be pharmacy benefit managers (PBMs), 
third party administrators and pharmacies, and the PDPs, MA-PDs, 
Fallbacks, and other plans that offer coverage of outpatient 
prescription drugs under the Medicare Part D benefit to Medicare 
beneficiaries. The statutorily required data is used primarily for 
payment and is used for claim validation as well as for other 
legislated functions such as quality monitoring, program integrity and 
oversight. In addition, the PDE data are used to support operations and 
program development.
    CMS has used PDE data to create summarized dashboards and tools, 
including the Medicare Part D Drug Spending Dashboard & Data, the Part 
D Manufacturer Rebate Summary Report, and the Medicare Part D Opioid 
Prescribing Mapping Tool. The data are also used in the Medicare 
Trustees

[[Page 45429]]

Report. Due to the market sensitive nature of PDE data, external uses 
of the data are subject to significant limitations. However, CMS does 
analyze the data on a regular basis to determine drug cost and 
utilization patterns in order to inform programmatic changes and to 
develop informed policy in the Part D program. Form Number: CMS-10174 
(OMB control number: 0938-0982); Frequency: Monthly; Affected Public: 
Private Sector, Federal Government; Number of Respondents: 856; Total 
Annual Responses: 1,499,064,780; Total Annual Hours: 62,918. (For 
policy questions regarding this collection contact Shelly Winston at 
(443) 934-3621.)

    Dated: July 12, 2023.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and 
Regulatory Affairs.
[FR Doc. 2023-15061 Filed 7-14-23; 8:45 am]
BILLING CODE 4120-01-P